The Effects of Caffeine on Physical Performance of Ice Hockey Players
Launched by UNIVERSIDAD DE ZARAGOZA · Dec 9, 2021
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years,
- • Male
- • Play in the Spanish ice hockey first division.
- Exclusion Criteria:
- • Participants taking drugs containing ephedrine or antibiotics.
- • Having suffered a musculoskeletal injury in the 3 months prior to the tests.
About Universidad De Zaragoza
The Universidad de Zaragoza, a prestigious institution in Spain, is dedicated to advancing scientific research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration, the university fosters a robust environment for conducting high-quality clinical studies that aim to improve healthcare outcomes. Leveraging its extensive academic resources and expertise across various medical fields, the Universidad de Zaragoza is committed to ethical research practices and the promotion of evidence-based medicine, contributing to the advancement of knowledge and the betterment of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials